Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

October 7, 2016

Primary Completion Date

January 9, 2019

Study Completion Date

January 9, 2019

Conditions
Acute Respiratory Viral Infections
Interventions
DRUG

Ergoferon

For oral use.

DRUG

Placebo

For oral use.

Trial Locations (13)

100000

Karaganda State Medical University, Karaganda

117997

"Federal State Budgetary Educational Institution of Higher Education Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation", Moscow

129515

"Limited Liability Company Diagnostics and Vaccines", Moscow

150000

Yaroslavl State Medical University/Children's Clinic # 5, Yaroslavl

Yaroslavl State Medical University/Clinical Hospital # 8, Yaroslavl

192071

"St. Petersburg State Budgetary Health Care Institution Сity Polyclinic №44", Moscow

400131

Volgograd State Medical University, Volgograd

420012

"Federal State Budgetary Educational Institution of Higher Education Kazan Medical University of the Ministry of Healthcare of the Russian Federation", Kazan'

443079

"State Budgetary Institution of Healthcare of the Samara Region Samara City Children's Clinical Hospital named after N.N. Willow New", Samara

614066

"Municipal Health Care Institution City Child Health Clinical Polyclinic №5", Perm

620028

"Municipal autonomous institution Children's City Clinical Hospital №11", Yekaterinburg

050057

Kazakh Medical Continuing Education University, Almaty

010000

Astana Medical University, Astana

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT03039621 - Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children | Biotech Hunter | Biotech Hunter